CBP/EP300-IN-2
Modify Date: 2024-01-03 10:33:15
CBP/EP300-IN-2 structure
|
Common Name | CBP/EP300-IN-2 | ||
|---|---|---|---|---|
| CAS Number | 2158265-96-2 | Molecular Weight | 521.56 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C27H29F2N7O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CBP/EP300-IN-2CBP/EP300-IN-2 is an inhibitor of CBP/EP300 with IC50 values of 1.07 nM and 5.96 nM for CBP/HTRF and Myc, respectively. CBP/EP300-IN-2, example 25, is extracted from patent WO2017205538A1[1]. |
| Name | CBP/EP300-IN-2 |
|---|
| Description | CBP/EP300-IN-2 is an inhibitor of CBP/EP300 with IC50 values of 1.07 nM and 5.96 nM for CBP/HTRF and Myc, respectively. CBP/EP300-IN-2, example 25, is extracted from patent WO2017205538A1[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50:1.07 nM (CBP/HTRF); 5.96 nM (Myc)[1] |
| References |
[1]. Patrick Cyr, et al. Pyrazolopyridine derivatives for the treatment of cancer |
| Molecular Formula | C27H29F2N7O2 |
|---|---|
| Molecular Weight | 521.56 |